Table 5.
ADRs in patients with NDO (safety population, n=161)
| Incidence of ADRs |
||
|---|---|---|
| No. (%) | No. of events | |
| Urinary system disorders | 3 (1.9) | 4 |
| Urinary retention | 1 (0.6) | 1 |
| Dysuria | 2 (1.2) | 2 |
| Difficulty in micturition | 1 (0.6) | 1 |
| Gastrointestinal system disorders | 1 (0.6) | 1 |
| Constipation | 1 (0.6) | 1 |
| Resistance mechanism disorders | 2 (1.2) | 2 |
| Urinary tract infecion | 2 (1.2) | 2 |
| Musculoskeletal system disorders | 2 (1.2) | 2 |
| Myalgia | 2 (1.2) | 2 |
| Reproductive disorders, male | 1 (0.6) | 1 |
| Testis disorder | 1 (0.6) | 1 |
| Total | 9 (5.6) | 10 |
ADRs, adverse drug reactions; NDO, neurogenic detrusor overactivity.